Skip to main content
logo
Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.310
+0.020 (0.61%)
At close: Aug 13, 2026, 4:00 PM EDT
3.300
-0.010 (-0.30%)
After-hours: Aug 13, 2026, 7:54 PM EDT

Recursion Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
54.8674.6858.8444.5839.8410.18
Revenue Growth
-15.08%26.92%32.00%11.88%291.46%156.89%
Gross Profit
1.913.7313.61.99-8.4310.18
Operating Income
-544.01-648.13-479-350.06-245.73-182.78
Net Income
-518.88-644.76-463.66-328.07-239.48-186.48
Earnings Per Share
-1.04-1.44-1.69-1.58-1.36-1.49
EPS Growth
------

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Research and Development Agreements
53.9474.2658.4943.8839.6810
Grant
0.920.430.350.70.160.18
Revenue (Total)
54.8674.6858.8444.5839.8410.18

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
545.68743.29594.35391.57549.91516.56
Total Debt
66.6477.97108.4950.6751.010.72
Net Cash (Debt)
479.05665.33485.86340.89498.91515.84
Net Cash Growth
9.61%36.94%42.52%-31.67%-3.28%106.63%
Net Cash Per Share
0.941.491.771.642.844.12

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-350.48-371.81-359.17-287.78-83.52-158.61
Capital Expenditures
-1.79-6.47-13.7-11.96-37.06-39.8
Free Cash Flow
-352.27-378.28-372.87-299.74-120.58-198.41
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
3.49%4.99%23.12%4.46%-21.16%100.00%
Operating Margin
-991.72%-867.87%-814.09%-785.33%-616.74%-1795.79%
Pretax Margin
-954.27%-863.53%-789.93%-745.10%-601.05%-1832.18%
Profit Margin
-945.92%-863.35%-788.02%-735.99%-601.05%-1832.18%
FCF Margin
-642.18%-506.52%-633.71%-672.43%-302.64%-1949.42%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
32.3628.9345.5951.8236.96286.58